Savant Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,700
Closed -$285K 1417
2025
Q3
$285K Buy
26,700
+6,525
+32% +$64K ﹤0.01% 1054
2025
Q2
$195K Sell
20,175
-1,677
-8% -$17.3K ﹤0.01% 1152
2025
Q1
$325K Buy
21,852
+3,835
+21% +$59K ﹤0.01% 818
2024
Q4
$269K Sell
18,017
-88,315
-83% -$1.44M ﹤0.01% 1167
2024
Q3
$2.03M Buy
106,332
+1,763
+2% +$36.5K 0.02% 422
2024
Q2
$2.16M Buy
104,569
+10,719
+11% +$213K 0.02% 352
2024
Q1
$1.76M Buy
+93,850
New +$1.61M 0.02% 392
2023
Q4
Sell
-12,954
Closed -$225K 865
2023
Q3
$225K Buy
+12,954
New +$270K ﹤0.01% 730

Other funds holding OGN

Savant Capital's OGN Position: Q4 2025 in Review

Savant Capital sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 26,700 shares — an estimated $285K sold.

Savant Capital first reported a position in OGN in Q3 2023 and held it in 8 quarters. The position peaked at $2.16M in Q2 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Savant Capital reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Savant Capital sold 26,700 Organon & Co shares in Q4 2025, an estimated $285K.
  • Savant Capital first reported a position in Organon & Co in Q3 2023 and held it in 8 quarters.
  • Savant Capital's Organon & Co position peaked at $2.16M in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Savant Capital's 13F filing for Q4 2025, filed 10 Feb 2026.